Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of PENNSAID for Pain Management in the Emergency Department

Next Previous
Trial Profile

Efficacy of PENNSAID for Pain Management in the Emergency Department

Status: Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 23 Dec 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Diclofenac (Primary) ; Diclofenac hydroxyethylpyrrolidine
  • Indications Musculoskeletal pain
  • Focus Therapeutic Use

Most Recent Events

  • 11 Apr 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
  • 08 Dec 2011 Planned end date changed from 1 Jun 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
  • 08 Dec 2011 Planned initiation date changed from 1 Jun 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top